Medicine and Dentistry
Tissues
92%
Nasal Polyp
84%
Eosinophilia
46%
Eosinophil Cationic Protein
46%
Polyp
38%
Recurrent Disease
30%
Chronic Rhinosinusitis
23%
Recurrence Risk
23%
Patient with Asthma
15%
Aspirin Exacerbated Respiratory Disease
15%
Follow up
7%
Prevalence
7%
Enzyme Linked Immunosorbent Assay
7%
Biological Marker
7%
Diagnosis
7%
Sinus Surgery
7%
Kaplan Meier Method
7%
Disease Severity
7%
Hazard Ratio
7%
Eosinophilic
7%
Proportional Hazards Model
7%
Asthma
7%
Haptocorrin
7%
Analysis
7%
Biopsy
7%
Nursing and Health Professions
Nose Polyp
84%
Eosinophilia
46%
Eosinophil Cationic Protein
46%
Polyp
38%
Recurrent Disease
30%
Patient
30%
Chronic Rhinosinusitis
23%
Recurrence Risk
23%
Comorbidity
15%
Aspirin-Induced Asthma
15%
Inpatient
15%
Follow up
7%
Enzyme Linked Immunosorbent Assay
7%
Kaplan Meier Method
7%
Prevalence
7%
Proportional Hazards Model
7%
Biological Marker
7%
Disease Severity
7%
Diagnosis
7%
Electronic Health Record
7%
Asthma
7%
Analysis
7%
Time
7%
Procedures
7%
Homogenate
7%
Haptocorrin
7%
INIS
tissues
100%
nose
84%
proteins
46%
eosinophils
46%
patients
23%
risks
23%
diseases
23%
levels
15%
surgery
15%
asthma
15%
aspirin
15%
correlations
7%
comparative evaluations
7%
biopsy
7%
biological markers
7%
enzymes
7%
hazards
7%
sinuses
7%
homogenates
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nose Polyp
84%
Eosinophilia
46%
Eosinophil Cationic Protein
46%
Polyp
38%
Recurrent Disease
30%
Recurrence Risk
23%
Chronic Rhinosinusitis
23%
Comorbidity
15%
Aspirin Exacerbated Respiratory Disease
15%
Prevalence
7%
Biological Marker
7%
Asthma
7%
Disease Severity
7%
Haptocorrin
7%